Previous Site visits

2017 Site Visits

 

Verily

March 24th, 2017

Verily (formerly Google Life Sciences) is developing tools to collect and organize health data, then creating interventions and platforms that put insights derived from that health data to use for more holistic care management. Current projects include a contact lens that senses glucose, an anti-tremor spoon, and the Baseline Study, a project to collect genetic and molecular information from enough people to create a picture of what a healthy human should be.

For more information, please visit  www.verily.com

 

2016 Site Visits

 

QB3@953

November 16th, 2016

In 2006, QB3, a multi-campus University of California research institute and accelerator headquartered at the Mission Bay campus of the University of California, San Francisco, repurposed a utility room into the QB3 Garage, the first technology incubator in the UC system. Of the first six startups through the Garage, four won Series A venture funding and a fifth was acquired within two years for $25 million. Over the following years, QB3 shoehorned incubators into several small sites at UCSF and UC Berkeley, and helped private affiliates launch two other spaces. More than 60 companies passed through these sites, creating hundreds of biotech jobs and bringing in over half a billion dollars of funding. When asked what they valued most in an incubator, the founders answered access to scientific equipment, being around other entrepreneurs, and access to potential corporate partners. In 2013, QB3 launched QB3@953, a full-service incubator purpose-built from the ground up offering laboratories, office space, meeting rooms, a la carte access to basics such as fridges, freezers, glasswash and autoclave, a stockroom, and an in-house staffed CRO facility with millions of dollars of equipment donated by partners like GE Healthcare, Miltenyi, American Laboratory Trading, and Corning. In addition, companies live in close proximity to founding partner JLABS and partners Amgen, Pfizer, and GSK, and with 50 companies onsite, QB3@953 has one of the richest community of scientists and entrepreneurs in the world to learn from and share experiences. QB3@953 is the leading biotech incubator in San Francisco - Enabling awesome, one bench at a time.

Caribou Biosciences

September 9th, 2016

Caribou Biosciences is an innovative biotech pioneering the translation of CRISPR-Cas genome editing techniques into new medical therapies. Caribou Bioscience is one of the leading companies working on the revolutionary gene editing technique CRISPR/Cas9, a prokaryotic system of defense against viral infections. This system can be adapted into a tool to edit out abnormal sections of genes, such as those involved in hereditary diseases. Co-founded by Prof. Jennifer Doudna, professor UC Berkeley and leader in the field, Caribou Biosciences aims to apply this genome editing technique toward a range of uses from drug research and development to industrial technology and agriculture. By collaborating with major pharmaceutical companies like Novartis and start-ups like Intellia, Caribou is pursuing to make a difference in cancer immunotherapy as well as viral infections and blood disorders.

 

Johnson & Johnson Innovation - JLabs

August 23, 2016

Johnson & Johnson Innovation team and JLABS have a breadth of startups with a range of expertise in several healthcare sectors, focusing on pharmaceuticals, medical devices and consumer products. Join us for a look at how emerging startups are succeeding throughout the tenuous process between early discovery and commercialization. At JLABS, startups receive all the support they'll need to build a foundation for success, with access to core research facilities full of specialized equipment, educational programs, operational support, and a community of like-minded entrepreneurs. In addition, the J&J innovation team, comprised of experienced professionals in business and science, provides guidance and support for the scientists and entrepreneurs hosted in the J&J incubator.

 

DuPont Industrial Biosciences

August 11, 2016

DuPont Industrial Biosciences works with customers across a wide range of industries to improve products and make processes more sustainable. Through a unique combination of agricultural, biotechnology, chemical and material science capabilities, coupled with the power of 2,500 talented individuals worldwide, the organization focuses on providing biobased solutions to meet the needs of a growing population while protecting our environment.

July 12, 2016

Exponent is a premier engineering and scientific consulting firm. Their multidisciplinary team of scientists, engineers, physicians, and regulatory consultants brings together more than 90 different disciplines to solve complicated problems facing corporations, insurers, government entities, associations, and individuals. Their 700+ consultants, including more than 425 that have earned a doctorate in their chosen field of specialization, work in 25 offices across the United States and abroad. They perform either in-depth scientific research and analysis, or very rapid-response evaluations, to provide clients with the critical information that both day-to-day and strategic decisions can require. They analyze failures and accidents to determine their causes and to understand how to prevent them, and evaluate complex human health and environmental issues to find cost-effective solutions.

 

 

April 19, 2016
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm. Since receiving approval for the first recombinant human erythropoetin product, Epogen, Amgen has gone on to receive approval for twelve drugs and biologics, treating seventeen conditions. Amgen has a presence in more than 75 countries worldwide and has reached millions of people in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. For more information please visit http://www.amgen.com. 
 
 
April 6, 2016
Medtronic is a medical device company headquartered in Dublin, Ireland, and is currently the largest standalone medical device company in the world. Since its beginnings as a company focused on treating irregular heartbeat, Medtronic has expanded into the fields of targeted drug delivery, surgical imaging, and patient diagnostics. Medtronic is composed of six main business units--Cardiac Rhythm Disease Management, Spinal And Biologics, Cardiovascular, Neuromodulation, Diabetes, Surgical Technologies, Technology Safety--which develop and manufacture devices and therapies to treat more than 30 chronic diseases. The Santa Rosa site is the home of the Cardiovascular Division, which includes the Endovascular, Coronary, and Structural Heart groups. 
 
 
 

 

March 18, 2016

Founded in 2009,Bolt Threads pioneered an environmentally-friendly textile, Bolt Threads Engineered SilkTM, the first new fabric since petrochemical-based polyester in 1950. Inspired by nature, Bolt engineered yeast to produce spider silk.  Why engineer silk? Performance and sustainability. Bringing versatile, softer, and longer-lasting textiles and garments to market promises to reduce oil consumption and water pollution caused by current textile processing. Bolt is currently optimizing their product for specific attributes like strength, stretch, or softness. This ability to tune their fibers opens limitless possibilities for creating new, innovative products.

 

  

 

February 12, 2016

Novartis is a Basel, Switzerland-based corporation that has grown to become the largest pharmaceutical company in the world. With an effective history spanning over 250 years, Novartis has a broad range of interests, from osteoporosis to heart disease to epilepsy and Parkinson's. These interests are supported by numerous research divisions in the fields of Metabolic Disease, Infectious Disease, Neuroscience, Vision Care, Oncology, and Cell and Gene Therapy.

For more information, please visit www.novartis.com

 

 

2015 Site Visits

 

 

November 18, 2015

Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. It employs more than 1,100 researchers, scientists and postdocs and covers a wide range of scientific activity—from molecular biology to protein chemistry to bioinformatics and physiology. Genentech scientists in these areas focus their efforts on five disease categories: Oncology, Immunology, Tissue Growth and Repair, Neuroscience, and Infectious Disease. 

 

 

 

September 18, 2015

Aduro Biotech, Inc. is a clinical-stage immuno-oncology company focused on the development of technology platforms to stimulate an immune response against cancer. Aduro's lead platform is based on proprietary strains of live-attenuated, double-deleted (LADD) Listeria monocytogenes that induce a potent innate immune response and have been engineered to express tumor-associated antigens to induce tumor-specific T cell-mediated immunity. Aduro has received Breakthrough Therapy designation from the FDA for its lead LADD regimen, CRS-207 in combination with GVAX Pancreas in pancreatic cancer. The company is evaluating the proprietary immuno-oncology combination in the ongoing Phase 2b ECLIPSE clinical trial and has additional ongoing clinical trials with its LADD platform in mesothelioma and glioblastoma. The company is also developing clinical candidates using cyclic dinucleotide (CDN) synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response.

 

August 13, 2015

Exponent is a premier engineering and scientific consulting firm. Their multidisciplinary team of scientists, engineers, physicians, and regulatory consultants brings together more than 90 different disciplines to solve complicated problems facing corporations, insurers, government entities, associations, and individuals. Their 700+ consultants, including more than 425 that have earned a doctorate in their chosen field of specialization, work in 25 offices across the United States and abroad. They perform either in-depth scientific research and analysis, or very rapid-response evaluations, to provide clients with the critical information that both day-to-day and strategic decisions can require. They analyze failures and accidents to determine their causes and to understand how to prevent them, and evaluate complex human health and environmental issues to find cost-effective solutions.

 

 

July 27, 2015

Invitae is a genetic information company whose mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of people.  Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today.

 

 

Catalent is a big company specializing in drug development and delivery, and serving as supply partner for drugs, biologics, and consumer health products. Recently they acquired Redwood Biosciences, located in Emeryville, for their SmartTag Technology. The Emeryville site specializes in this SmartTag technology for synthesizing optimized antibody-drug conjugates. Their technology involves protein engineering, protein expression, cell line development, and pre-clinical studies.

 

Gilead Sciences

April 7, 2015

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. With each new discovery and experimental drug candidate, Gilead seeks to improve the care of patients suffering from life-threatening diseases around the world. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation.

 

Sutro

March 19, 2015

Sutro Biopharma, Inc. develops best-in-class antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Sutro’s make-test cycle takes approximately two weeks, enabling broader and deeper biologics discovery and development efforts than can be accomplished with current cell-based expression technologies. Once identified, production of protein drug candidates can be rapidly and predictably scaled in Sutro’s cGMP manufacturing facility. In addition to developing its own drug pipeline, Sutro Biopharma is collaborating with select pharmaceutical and biotech companies to discover and develop novel therapeutics.

 

LakePharma

March 6, 2015

LakePharma is a leading contract research organization (CRO) in the Bay Area specializing in antibody and protein engineering, cell line development, and protein production. It is keen at innovating and implementing the best technologies in order to provide low cost and high quality services to its customers. A number of high efficiency gene expression systems for protein and antibody production have been developed in house since its foundation in 2003.

 


 

2014 Site Visits

 

Thermo Fisher Scientific

November 14, 2014

Thermo Fisher Scientific is an international biotechnology product development company, with revenues of $17 billion and 50,000 employees in 50 countries. They have four premier brands: Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its South San Francisco site is staffed by around 650 employees, working primarily on R&D. The areas of R&D focus include Human Identification, Capillary Electrophoresis, qPCR and Ion TorrentTM semiconductor sequencing.

 

October 14, 2014

Facebook is an online social networking service company. Founded in 2004, its mission is to give people the power to share and make the world more open and connected. People use Facebook to stay connected with friends and family, to discover what’s going on in the world, and to share and express what matters to them. Facebook develops technologies that facilitate the sharing of information through the social graph, the digital mapping of people's real-world social connections. As of January 2014, Facebook had more than 6,000 employees worldwide.

 

Triple Ring

August 19, 2014

Triple Ring Technologies is an on-demand core technology and product creation lab, serving partners in regulated industries. Triple Ring has successfully completed over 300 projects for confidential clients. Their headquarters (Newark, CA) consists of 96,000 sq. ft. of flexible space that includes laboratories for electronics, optics, radiation source development, mechanical prototyping; systems integration, client drop-in offices; and pilot manufacturing. Triple Ring builds regulated technologies and complex products and offers a full range of related technical and business services: analysis and creation of intellectual property; development and implementation of technology strategy; design and development of engineering prototypes and released products; feasibility studies and testing; due diligence and situation analysis; and advisory services on regulatory compliance and technology pathways. Above all, Triple Ring works collaboratively to build novel technologies and products. 

 

QB3

June 24, 2014

The garage is the paradigm for the Silicon Valley startup—think Apple or HP. However, real garages are not suitable for biology experiments. Biotech entrepreneurs have a much harder time moving from idea to prototype, which reduces the rate of innovation. To address this challenge, QB3 created two incubators that allow startups access to rental laboratory space close to UC faculty. These incubators, the QB3 Garage@UCSF and the QB3 Garage@Berkeley, are the biotech equivalent of garages: small spaces for entrepreneurs to lay the foundations for companies that may spearhead new industries. In 2013 we launched QB3@953, a full-service, standalone biotech incubator near the UCSF Mission Bay campus. This site visit will include an introduction to QB3 incubators and a tour of QB3's newest incubator, QB3@953.

 

Monsanto

May 21, 2014

Monsanto is a sustainable agriculture company.  Monsanto delivers agricultural products that support farmers all around the world. They are focused on empowering farmers—large and small—to produce more from their land while conserving more of our world's natural resources such as water and energy.  Monsanto does this with their leading seed brands in crops like corn, cotton, oilseeds and fruits and vegetables.  Monsanto also produces leading in-the-seed trait technologies for farmers, which are aimed at protecting their yield, supporting their on-farm efficiency and reducing their on-farm costs.

 

BioRad

April 3, 2014

Bio-Rad Laboratories, based in Hercules, CA, was founded in 1952 and plays a leading role in the development of both innovative Life Sciences research and Clinical Diagnostics tools. The company has a global operative network and serves customers worldwide. A major emphasis lays in a strong relationship to  customers, which supports advances and innovation in research and new technologies in a broad range of research areas.

 


 

2013 Site Visits

 

Plexxikon

Plexxikon is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery platform to successfully develop a portfolio of competitively differentiated clinical and preclinical stage programs in a number of therapeutic areas and disease indications. Plexxikon’s platform enables the design of highly selective and targeted medicines, supporting the company’s broader strategy to develop personalized medicines.

 

Genentech logo

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.

 

Fluidigm Logo

Fluidigm is a biotech tools company that creates microfluidic-based chips and instrumentation for biological research.  Fluidigm’s technology enables the rapid, efficient, highly parallel, and reproducible analysis of tens-to-hundreds of genetic markers, across hundreds-or-thousands of DNA samples, in hours instead of days or weeks.  Fluidigm’s technology supports genomics-based applications such as single-cell gene expression, high sample throughput SNP genotyping and ground-breaking capabilities such as digital PCR and automated target enrichment for next-generation sequencing.

 

Nektar Logo

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient.

 

Boehringer Ingelheim Logo

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. They are committed to offering the highest quality products to treat diseases, enhance health, and improve the quality of life for patients and their families.

 

California Department of Public Health Logo

The California Department of Public Health is dedicated to optimizing the health and well-being of the people in California. CDPH achieves its mission through the following core activities:

1) Promoting healthy lifestyles for individuals and families in their communities and workplaces.

2) Preventing disease, disability, and premature death and reducing or eliminating health disparities.

3) Protecting the public from unhealthy and unsafe environments.

4) Providing or ensuring access to quality, population-based health services.

5) Preparing for and responding to public health emergencies.

6) Producing and disseminating data to inform and evaluate public health status, strategies and programs.

 


 

2012 Site Visits

 

Amgen Logo
Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A leader in biotechnology since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology, and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.


Gilead Logo
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and experimental drug candidate, we seek to improve the care of patients suffering from life-threatening diseases around the world. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation.


Agilent Technologies Logo
As the world's premier measurement company, Agilent offers the broadest range of innovative measurement solutions in the industry. The company's four businesses – Chemical Analysis, Life Sciences, Diagnostics and Genomics, and Electronic Measurement -- provide customers with products and services that make a real difference in the lives of people everywhere.  And at Agilent Research Laboratories, we conduct research that anticipates customer needs and produces breakthroughs that power growth.


qb3 logo
The QB3-EBIC “Bakery” incubator provides 9,300 square feet of top-quality wet-laboratories, support functions, private offices, lunch/break area, and conference rooms specifically designed to meet the needs of start-up technology companies. The facility contains a number of major items of research equipment that are available for use by tenants, including fume hoods, bio-safety cabinets, incubators, freezers, ultra low temperature freezers, an ice machine, and an autoclave. The central location in the East Bay technology corridor, less than 15 minutes away from the UC Berkeley and LBNL campuses, provides access to the world class scientific communities at these major research institutions and at local and international companies such as Novartis, Bayer HealthCare, Amyris, XOMA, and Dynavax.


Redwood Bioscience logo
Redwood Bioscience is utilizing precision protein-chemical engineering for drug conjugate optimization.  Hybrid therapeutics are emerging as an important class of drugs.  These products combine  the binding specificity and half-life benefits of biologic “carriers”,  with the potency advantages of small molecule and synthetic peptide ”cargo”.  Redwood’s site specific protein modification technology overcomes the challenges associated with conjugating biologics to synthetic molecules.  The Company’s approach provides control and flexibility over cargo location and loading on a carrier, producing homogenous therapeutics.  The chemical orientation of a payload can be optimized to enhance drug-target interactions for improved conjugate potency.  Control over cargo placement, number and orientation enables generation of chemically modified protein libraries for optimal conjugate selection.


Intrexon logo
Intrexon Corporation is a privately held biotechnology company focused on the industrial engineering of synthetic biology. Intrexon is deploying its extensive capabilities to rapidly design and produce novel and enhanced biological products and processes across multiple industry sectors, including: human therapeutics, protein production, industrial products, agricultural biotechnology, and animal science. The company's advanced bioindustrial engineering platform enables Better DNA™ technology by combining revolutionary DNA control systems with corresponding advancements in modular transgene design, assembly, and optimization to enable unprecedented control over the function and output of living cells.


Spiral Devices logo
Spiral Devices LLC is a startup biotechnology company committed to developing and commercializing technologies to improve the in vivo delivery of biological molecules for studying and treating disease.

 

Lygos logo
Lygos develops high-efficiency, novel processes to renewable chemicals by using our expertise in synthetic biology and metabolic engineering.

 

 Genecor logo

DuPont Industrial Biosciences works with customers across a wide range of industries to improve products and make processes more sustainable. Through a unique combination of agricultural, biotechnology, chemical and material science capabilities, coupled with the power of 2,500 talented individuals worldwide, the organization focuses on providing biobased solutions to meet the needs of a growing population while protecting our environment.  


23andMe logo
23andMe is a personal genomics company based in Mountain View, CA that provides direct-to-consumer genetic testing for both disease prediction and ancestry identification.  In addition to having provided genetic information to more than 100,000 people, 23andMe is actively researching the genetic causes of human diseases, notably Parkinson’s Disease and several forms of cancer.

 


 

2011 Site Visits

  

Life Technologies logo
Life Technologies Corporation is a global biotechnology company dedicated to improving the human condition. Their systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products.

 


Novartis logo
At the Novartis Institutes for BioMedical Research (NIBR), the goal is to discover new medicines regularly based on an understanding of molecular mechanisms of disease. NIBR scientists are exploring the intersection of the chemical and biological universes, their focus being medicine combined with bioinformatics, genetics, and imaging tools as well as new chemical and screening technologies. The result: an integrative/reductionist combination that renders the drug discovery process at Novartis a true scientific frontier. Since 2000 Novartis has had the greatest number of new molecular entities approved by the FDA for clinical use in the United States. With our ongoing focus on diseases with unmet medical needs, NIBR scientists ensure that Novartis maintains its robust pipeline and successful track record in innovative drug discovery.

 


qb3 logo
QB3 was founded in 2000 as one of four Governor Gray Davis Institutes for Science and Innovation (ISI). The Institutes were launched in 2000 as an ambitious statewide initiative to support research in fields that were recognized as critical to the economic growth of the state—biomedicine, bioengineering, nanosystems, telecommunications and information technology. Moreover, the Cal ISIs were conceived as a catalytic partnership between university research interests and private industry that could expand the state economy into new industries and markets and “speed the movement of innovation from the laboratory into peoples' daily lives”. The four research centers operate as a partnership among the University, state government, and industry, and each involves structured collaborations among campuses, disciplines, academics researchers, research professional, and students.

 

Allopartis logo
Allopartis Biotechnologies develops tailored industrial and therapeutic proteins using the AlloScreen, an innovative high-throughput enzyme optimization platform. By eliminating the need for cell culture and robotic screening, our patented system is dramatically faster than conventional methods. Built on next-generation DNA sequencing concepts, the platform integrates three components—emulsions, directed evolution, and solid substrate particles—with an innovative approach to selecting enhanced proteins.

 


Refactored Materials logo
Refactored Materials takes high value natural materials that are too scarce or expensive to extract from nature (e.g., spider silk) and uses a combination of synthetic biology and microfabrication to create commercially scalable products. The first product is natural dragline spider silk adapted for commercial scale production.

 


LS9 logo
LS9’s vision is to provide practical, cost effective solutions to address a number of global concerns. Our vision leverages our leadership in industrial biotechnology and synthetic biology to deliver sustainable products that are derived from abundant renewable resources. Our passion is to catalyze a rapid and widespread transition to renewables and to improve the economic, political, and environmental health of our planet through new industries and jobs, renewable raw materials, and sustainable products and practices.

 


Bio-Rad logo
Bio-Rad Laboratories continues to play a leading role in the advancement of scientific discovery by offering a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 7,000 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations. Throughout its existence, Bio-Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more.